Evolving Innovations
Evolving Innovations
Description: A nanoviricide Against All Influenzas - Biomimetic Fooling Viruses - NNVC
mers (24) middle east respiratory syndrome (1) mers virus (1) mers flu (1) nnvc inc (1) nnvc (1) nanoviricides incorporated (1) nanoviricides (1) middle east respiratory syndrome (mers) (mers)
May 4, 2023 - NANOVIRICIDES, INC. TO PRESENT AT THE INAUGURAL EF HUTTON GLOBAL CONFERENCE ON MAY 10,2023 IN NEW YORK CITY April 25, 2023 - NanoViricides is Expanding its Broad-Spectrum Antiviral Program to Explore Further Antiviral Applications of its COVID Clinical Drug Ingredient April 17, 2023 - NanoViricides Has Shipped Drug Products for Impending Clinical Trials of NV-CoV-2, Its COVID Drug Candidate April 5, 2023 - NanoViricides Signs a License Agreement That Includes Clinical Evaluation of Its COVID-1
Imagine coursing through the blood stream, chasing through the body, grabbing and destroying the offending virus particles. NanoViricides, Inc. is striving to bring this imagination to fruition. A nanoviricide®, as defined by the Company, is a nanomachine that is armed to destroy a particular kind of virus. Which virus? That information is programmed into the nanoviricide, akin to the postal address on an envelope.
A "nanoviricide" is an agent designed by the Company to fool a virus into attaching to this antiviral nanomachine, in the same way that the virus normally attaches to the receptors on a cell surface. Once attached, the flexible nanoviricide glob wraps around the virus and traps it. In the process, the virus also loses its coat proteins that it needs to bind to a cell. The virus is thus neutralized and effectively destroyed. A nanoviricide completes the task of dismantling the virus particle without immune s
Evolving Innovations
Evolving Innovations